LAVYX | VIVAX | LAVYX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 21 years | 32 years | - |
Gain YTD | 18.541 | 16.261 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.04B | 183B | 1% |
Annual Yield % from dividends | 0.94 | 2.25 | 42% |
Returns for 1 year | 29.31 | 23.98 | 122% |
Returns for 3 years | 14.55 | 28.28 | 51% |
Returns for 5 years | 31.53 | 55.44 | 57% |
Returns for 10 years | 8.27 | 113.95 | 7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMRGX | 7.03 | 0.03 | +0.43% |
Emerging Markets Growth Fund M | |||
EAMAX | 16.05 | N/A | N/A |
Lord Abbett Emerging Markets Equity A | |||
SPUSX | 16.51 | N/A | N/A |
Symmetry Panoramic US Equity I | |||
TOVIX | 18.62 | -0.06 | -0.32% |
American Beacon EAM Int Small Cap R5 | |||
FCVAX | 20.10 | -0.19 | -0.94% |
Fidelity Advisor Small Cap Value A |